B. J. Lipworth, Airway and systemic effects of inhaled corticosteroids in asthma: 136 dose response relationship, Pulm Pharmacol, vol.9, pp.19-27, 1996.

R. Arrington-sanders, N. Hutton, and G. K. Siberry, Ritonavir-fluticasone interaction 138 causing Cushing syndrome in HIV-infected children and adolescents, Pediatr. Infect. Dis, 2006.

, J, vol.25, pp.1044-1048

D. R. Woods, C. S. Arun, P. A. Corris, and P. Perros, Cushing's syndrome without excess 142 cortisol, BMJ, vol.332, pp.469-470, 2006.

J. Wong and P. Black, Acute adrenal insufficiency associated with high dose inhaled 145 steroids, BMJ, vol.304, p.1415, 1992.

A. Monoz-cortes, A. Montesdeoca, -. Boada, C. Del-campo, and . Garcia-sanchez,

M. Colomer, E. Fernandez-quintana, and M. Garcia-saiz, Interaction between 149 voriconazole and budesonide with clinical relevance (Cushing's syndrom), 2011.

, Abstracts. Basic & Clinical Pharmacology & Toxicology, vol.109, pp.41-71

D. Wexler, R. Courtney, W. Richards, C. Banfield, J. Lim et al., Effect of 153 posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way 154 crossover study, Eur J Pharm Sci, vol.21, pp.645-653, 2004.

V. N. Ba, S. Cetinkaya, and Z. Aycan, Iatrogenic Cushing syndrome due to nasal 157 steroid drops, Eur. J. Pediatr, vol.171, pp.735-736, 2012.

W. C. Hoover, L. J. Britton, J. Gardner, T. Jackson, and H. Gutierrez, Rapid onset of 160 iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease 161 treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor, Ann, vol.162, p.38, 2011.

A. Daveluy, C. Raignoux, G. Miremont-salamé, P. Girodet, and N. Moore, , p.165

F. , M. Foisy, M. M. Yakiwchuk, E. Chiu, I. Singh et al., Drug interactions between inhaled corticosteroids and enzymatic 166 inhibitors, Eur. J. Clin. Pharmacol, vol.65, p.169, 2008.

, Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a 170 review of the literature, HIV Med, vol.9, pp.389-396

T. W. Felton, C. Baxter, C. B. Moore, S. A. Roberts, W. W. Hope et al., , 2010.

, Efficacy and safety of posaconazole for chronic pulmonary aspergillosis, Clinical 174 infectious diseases, vol.51, pp.1383-1391

A. Cornillet, C. Camus, S. Nimubona, V. Gandemer, P. Tattevin et al., , p.177

S. Chevrier, C. Meunier, C. Lebert, M. Aupée, S. Caulet-maugendre et al., , p.178

B. Lelong, E. Leray, C. Guiguen, and J. Gangneux, Comparison of epidemiological, p.179, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00699980

, biological features of invasive aspergillosis in neutropenic and 180 nonneutropenic patients: a 6-year survey, Clin. Infect. Dis, vol.43, pp.577-584